The emerging approach of the medication represents a major development in the management of diabetes mellitus type 2. Distinct from existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP hormone – leading to enhanced glucose regulation and potential